SOLID BIOSCIENCES INC's ticker is SLDB and the CUSIP is 83422E105. A total of 62 filers reported holding SOLID BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $87,000 | -37.4% | 187,100 | -17.4% | 0.00% | – |
| Q2 2022 | $139,000 | -69.0% | 226,600 | -39.2% | 0.00% | -100.0% |
| Q1 2022 | $448,000 | -55.5% | 373,000 | -35.1% | 0.00% | -66.7% |
| Q4 2021 | $1,006,000 | -23.1% | 574,700 | +4.9% | 0.00% | 0.0% |
| Q3 2021 | $1,309,000 | -75.9% | 547,800 | -63.1% | 0.00% | -78.6% |
| Q2 2021 | $5,430,000 | +43.5% | 1,483,600 | +116.9% | 0.01% | +40.0% |
| Q1 2021 | $3,783,000 | +57.2% | 684,000 | +115.4% | 0.01% | +66.7% |
| Q4 2020 | $2,407,000 | +638.3% | 317,600 | +97.8% | 0.01% | +500.0% |
| Q3 2020 | $326,000 | -24.0% | 160,600 | +9.7% | 0.00% | 0.0% |
| Q2 2020 | $429,000 | +108.3% | 146,400 | +69.8% | 0.00% | 0.0% |
| Q1 2020 | $206,000 | +261.4% | 86,200 | +573.4% | 0.00% | – |
| Q4 2019 | $57,000 | – | 12,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,871,164 | $11,343,000 | 1.19% |
| Perceptive Advisors | 6,749,803 | $19,777,000 | 0.32% |
| RA Capital Management | 4,571,164 | $13,394,000 | 0.26% |
| Boxer Capital, LLC | 1,531,872 | $4,488,000 | 0.20% |
| Ikarian Capital, LLC | 788,008 | $2,309,000 | 0.18% |
| Eversept Partners, LP | 407,024 | $1,192,580 | 0.16% |
| Artal Group S.A. | 1,800,000 | $5,274,000 | 0.15% |
| Matisse Capital | 24,500 | $72,000 | 0.02% |
| Old Well Partners, LLC | 10,023 | $29,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 10,431 | $31,000 | 0.02% |